MM Tool Update
Multiple Myeloma Care Is Changing, and the Treatment Decision Support Tool Is Keeping Pace

Released: June 22, 2023

Joseph Mikhael
Joseph Mikhael, MD, MEd, FRCPC, FACP

Activity

Progress
1
Course Completed
Key Takeaways
  • The treatment paradigm for multiple myeloma is evolving quickly.
  • A team of 5 experts in multiple myeloma has updated our interactive treatment decision support tool to assist you with clinical decision-making in your practice today.

Interactive Decision Support Tool

The treatment landscape of multiple myeloma is continually evolving. To aid in treatment decisions encompassing the spectrum of multiple myeloma, my colleagues and I have developed an  Interactive Decision Support Tool covering the induction, maintenance, and relapsed/refractory settings (Figure 1). This tool has been created, evaluated, and designed by 5 experts who treat patients with multiple myeloma. As a user of the tool, you can input key patient and disease characteristics to define a patient scenario.

Figure 1. Entering patient and disease characteristics into the tool.

After entering key patient and disease characteristics, you select your intended treatment choice. Then you will be shown the recommendations from all 5 experts for your individual set of characteristics, along with a link to additional information to consider (Figure 2).

Figure 2. Expert treatment recommendations.

When you have a patient in front of you, this tool will help inform the decision-making that needs to occur and the process you should consider in ultimately individualizing treatment for that person.

Additional Resources

For further information on key trials, expert perspectives, discussion, and more on the latest treatment options for multiple myeloma, check out the following program page.

Your Thoughts?

What are your suggestions for our updated multiple myeloma Interactive Decision Support Tool? Please answer the polling question and join the conversation by posting a comment in the discussion section.

Poll

1.

Which of the following topics in multiple myeloma would you like to get more expert insight on?

Submit